Gorzko, A.; Melnyk, M.; Nawrocka-Rutkowska, J.; Starczewski, A.; Marciniak, A.; Szydłowska, I.
Evaluation of Anti-Müllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI). J. Clin. Med. 2025, 14, 2677.
https://doi.org/10.3390/jcm14082677
AMA Style
Gorzko A, Melnyk M, Nawrocka-Rutkowska J, Starczewski A, Marciniak A, Szydłowska I.
Evaluation of Anti-Müllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI). Journal of Clinical Medicine. 2025; 14(8):2677.
https://doi.org/10.3390/jcm14082677
Chicago/Turabian Style
Gorzko, Amalia, Mariia Melnyk, Jolanta Nawrocka-Rutkowska, Andrzej Starczewski, Aleksandra Marciniak, and Iwona Szydłowska.
2025. "Evaluation of Anti-Müllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI)" Journal of Clinical Medicine 14, no. 8: 2677.
https://doi.org/10.3390/jcm14082677
APA Style
Gorzko, A., Melnyk, M., Nawrocka-Rutkowska, J., Starczewski, A., Marciniak, A., & Szydłowska, I.
(2025). Evaluation of Anti-Müllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI). Journal of Clinical Medicine, 14(8), 2677.
https://doi.org/10.3390/jcm14082677
